Background: Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer effect with cisplatin and to reduce the side effects of cisplatin in melanoma-bearing mice.Methods: HemoHIM was prepared by adding the ethanol-insoluble fraction to the total water extract of a mixture of 3 edible herbs, Angelica Radix, Cnidium Rhizoma and Paeonia Radix. Anticancer effects of HemoHIM with cisplatin were evaluated in melanoma-bearing mice. We used a Cr51-release assay to measure the activity of NK/Tc cell and ELISA to evaluate the production of cytokines.Results: In melanoma-bearing mice, cisplatin (4 mg/kg B.W.) reduced the size and weight of the solid tumors, and HemoHIM supplementation with cisplatin enhanced the decrease of both the tumor size (p < 0.1) and weight (p < 0.1). HemoHIM itself did not inhibit melanoma cell growthin vitro, and did not disturb the effects of cisplatinin vitro. However HemoHIM administration enhanced both NK cell and Tc cell activity in mice. Interestingly, HemoHIM increased the proportion of NK cells in the spleen. In melanoma-bearing mice treated with cisplatin, HemoHIM administration also increased the activity of NK cells and Tc cells and the IL-2 and IFN-γ secretion from splenocytes, which seemed to contribute to the enhanced efficacy of cisplatin by HemoHIM. Also, HemoHIM reduced nephrotoxicity as seen by tubular cell of kidney destruction.Conclusion: HemoHIM may be a beneficial supplement during cisplatin chemotherapy for enhancing the anti-tumor efficacy and reducing the toxicity of cisplatin.
Buddleja officinalis has been traditionally used in the supportive treatment of inflammatory and neuronal diseases in Korea and China. Although several reports have shown the anti-inflammatory effects of Buddleja officinalis, the anti-neuroinflammatory effect has remained unclear. In this study, we aimed to investigate the inhibitory effects of flower buds of B. officinalis Maximowiczwater extract (BOWE) on LPS-induced inflammatory processes in BV-2 microglial cells. BOWE dose-dependently inhibited the production of nitric oxide as well as iNOS mRNA expression. Moreover, BOWE prevented IL-1β and IL-6 mRNA expression. However, BOWE had no effect on LPS-induced COX-2 or TNF-a mRNA expression. The extract also had no effect on LPS-stimulated p38 MAPK, JNK, and c-Jun phosphorylation, whereas ERK1/2 phosphorylation was strongly inhibited by BOWE. BOWE also inhibited the LPS-induced degradation of IkB-α, and LPS-induced phosphorylation of p65 NF-kB protein. These data indicate that BOWE inhibited the nitric oxide production and pro-inflammatory gene expression in BV-2 microglial cells, possibly through a negative regulation of the NF-kB and ERK1/2 pathways. Further identification of the direct target molecule(s) of BOWE is required to support its use as an anti-neuroinflammatory agent against the neurodegenerative disorders.
1 March 2005 in International Journal of Radiation Biology
Ionizing radiation is known to reduce the helper T (Th) 1-like function, but not the Th2-like function, resulting in a Th1/Th2 imbalance. While this has been known for some time, the mechanism behind the preferential suppression of the Th1 cell activation has not yet been explained. The aim is to elucidate the mechanism in the Th cell imbalance after ionizing irradiation. C57BL/6 mice, 7 weeks old, received whole-body γ-irradiation (WBI) of 5 Gy. In all instances, the spleen and peritoneal cells were obtained from mice 7 weeks after irradiation. To distinguish Th1 and Th2 cell function, interferon (IFN)-γ and interleukin (IL)-4 produced by these cells were analysed by an enzyme-linked immunosorbent assay (ELISA). To isolate the primary T cells, the anti-CD90.2 microbead-conjugated antibody was used and the labelled cells were separated by magnetic cell sorting (MACS). To investigate the influence of the IL-12p70 secreted by the antigen-presenting cells, ovalbumin (OVA)-primed peritoneal adherent cells (PAC) were fixed by 1% paraformaldehyde and co-cultured with OVA-specific Th cells in the presence of supernatant of PAC culture with OVA for 16 h. IL-12 receptor, signal transducers and activators of transcription 4 (STAT4) and IFN-γ expression in the T cells of the WBI mice were detected by reverse transcriptase-polymerase chain reaction (RT-PCR). The spleen lymphocytes of WBI mice showed a depression of IFN-γ production against OVA, although the total IL-12 was highly secreted. However, the heterodimer IL-12, biologically active protein, was induced less in WBI mice. Although the OVA-specific Th cells were co-cultured with fixed OVA-primed PAC obtained from normal mice, the OVA-specific Th cells showed a decreased IFN-γ secretion in the presence of the culture supernatant of the activated PAC from the WBI mice. In addition, recombinant IL-12p70 restored the cytokine balance of the OVA-specific Th cells. However the cytokine balance of primary T cells from WBI mice was not completely restored by the normal antigen-presenting cells that abundantly secrete IL-12p70. It was assumed that after WBI, the regenerated T cells also have some problems. It was then observed that the IL-12 receptor expression and intracellular levels of the STAT4 were much lower in the T cells of the WBI mice. The results suggest that the shifted response of the helper T cells after WBI exposure is due not only due to a significant suppression of the secretion of the IL-12p70 in the antigen-presenting cells, but also to the lower expression of the IL-12 receptor on T cells.
1 January 2006 in International Journal of Radiation Biology
Ionizing radiation is known to reduce the helper T (Th) 1 like function, resulting in a Th1/Th2 imbalance. We studied whether NK1.1+T cells which were the most resistant against gamma-irradiation impact on the imbalanced immune response after irradiation. C57BL/6 mice received a whole-body gamma-irradiation (WBI) of 4 Gy. The primary T cells were separated by magnetic cell sorter (MACS) using the anti-CD90.2 antibody. The apoptotic cells were detected by propidium iodide (PI) staining. To determine the Th1 and Th2 cell functions, the production of interferon (IFN)-gamma and interleukin (IL)-4 were analysed by a reverse transcriptase-polymerase chain reaction (RT-PCR) and an enzyme linked immunosorbent assay (ELISA). NK1.1+T cells were detected by flow cytometry. For depletion of the NK1.1+T cells in the WBI mice, anti-asialo GM1 antiserum was injected. The CD90.2 positive cells of the WBI mice produced significantly more Th2 type cytokines and also produced Th1 type cytokines at a not lower level than normal mice, and contained a higher absolute number of NK1.1+T cells. Also, the proportion of the NK1.1+T cells increased in the WBI mice. We found that the NK1.1+T cells were resistant to radiation-induced apoptosis in comparison with the conventional T cells. The depletion of NK1.1+T cells in WBI mice resulted in higher production of IgE and IL-4 and lower secretion of IL-12p70. Our findings revealed that NK1.1+T cells that survive at an early stage after irradiation play an important role in the balance of the immune responses at a late stage after irradiation.
Cancer stem cells (CSCs) play an important role in cancer recurrence and metastasis. It is suggested that the CSC properties in heterogeneous cancer cells can be induced by ionizing radiation (IR). This study investigated the role of DLX2 in the radioresistance and CSC properties induced by IR in NSCLC cancer cells. Here, A549 cells were exposed to fractionated irradiation at a cumulative dose of 52 Gy (4 Gy × 13 times) for a generation of radioresistant cells. After fractionated irradiation, surviving A549 cells exhibited resistance to IR and enhanced expression of various cancer stem cell markers. They also showed upregulation of mesenchymal molecular markers and downregulation of epithelial molecular markers, correlating with an increase in the migration and invasion. Fractionated irradiation triggered the secretion of TGF-β1 and DLX2 expression. Interestingly, the increased DLX2 following fractionated irradiation seemed to induce the expression of the gene for the EGFR-ligand betacellulin via Smad2/3 signaling. To contrast, DLX2 knockdown dramatically decreased the expression of CSC markers, migration, and proliferation. Moreover, A549 cells expressing DLX2 shRNA formed tumors with a significantly smaller volume compared to those expressing control shDNA in a mouse xenograft assay. These results suggest that DLX2 overexpression in surviving NSCLC cancer cells after fractionated IR exposure is involved in the cancer stemness, radioresistance, EMT, tumor survival, and tumorigenic capability.